JP5433690B2 - 抗−hiv薬としてのジケト縮合アゾロピペリジンおよびアゾロピペラジン - Google Patents
抗−hiv薬としてのジケト縮合アゾロピペリジンおよびアゾロピペラジン Download PDFInfo
- Publication number
- JP5433690B2 JP5433690B2 JP2011516575A JP2011516575A JP5433690B2 JP 5433690 B2 JP5433690 B2 JP 5433690B2 JP 2011516575 A JP2011516575 A JP 2011516575A JP 2011516575 A JP2011516575 A JP 2011516575A JP 5433690 B2 JP5433690 B2 JP 5433690B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- alkyl
- formula
- conr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- UKJPUSRPOKIYGG-UHFFFAOYSA-N CC(C)(C)OC(N(CC[n]12)Cc1nc(N)c2[AlH2])=O Chemical compound CC(C)(C)OC(N(CC[n]12)Cc1nc(N)c2[AlH2])=O UKJPUSRPOKIYGG-UHFFFAOYSA-N 0.000 description 1
- CFRROVZTUGGIRN-UHFFFAOYSA-N CC(C)(C)OC(N(CC[n]12)Cc1ncc2[AlH]C)=O Chemical compound CC(C)(C)OC(N(CC[n]12)Cc1ncc2[AlH]C)=O CFRROVZTUGGIRN-UHFFFAOYSA-N 0.000 description 1
- NOESCOSQXJBDAR-UHFFFAOYSA-N C[AlH]c1c(N)nc2[n]1CCNC2 Chemical compound C[AlH]c1c(N)nc2[n]1CCNC2 NOESCOSQXJBDAR-UHFFFAOYSA-N 0.000 description 1
- 0 C[Al]c1c(N)nc(C2)[n]1CCN2C(C(*)=O)=O Chemical compound C[Al]c1c(N)nc(C2)[n]1CCN2C(C(*)=O)=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7537408P | 2008-06-25 | 2008-06-25 | |
US61/075,374 | 2008-06-25 | ||
PCT/US2009/048427 WO2009158394A1 (en) | 2008-06-25 | 2009-06-24 | Diketo azolopiperidines and azolopiperazines as anti-hiv agents |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011526283A JP2011526283A (ja) | 2011-10-06 |
JP2011526283A5 JP2011526283A5 (US20040106767A1-20040603-C00005.png) | 2012-07-26 |
JP5433690B2 true JP5433690B2 (ja) | 2014-03-05 |
Family
ID=41137086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011516575A Expired - Fee Related JP5433690B2 (ja) | 2008-06-25 | 2009-06-24 | 抗−hiv薬としてのジケト縮合アゾロピペリジンおよびアゾロピペラジン |
Country Status (6)
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1993979A4 (en) | 2006-02-03 | 2011-07-06 | Grt Inc | CONTINUOUS PROCESS FOR CONVERTING NATURAL GAS TO LIQUID HYDROCARBONS |
ES2636312T3 (es) * | 2011-04-12 | 2017-10-05 | VIIV Healthcare UK (No.5) Limited | Derivados de tioamida, amidoxima y amidrazona como inhibidores de la fijación del VIH |
US8835454B2 (en) | 2011-08-29 | 2014-09-16 | Bristol-Myers Squibb Company | Fused bicyclic diamine derivatives as HIV attachment inhibitors |
NZ627560A (en) | 2012-01-25 | 2016-08-26 | Novartis Ag | Heterocyclic piperazine compounds and methods for their use |
BR112014019289A8 (pt) | 2012-02-08 | 2017-07-11 | Bristol Myers Squibb Co | Métodos para a preparação do composto de prome-dicamento de piperazina inibidor da ligação do hiv |
JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
WO2014025852A1 (en) * | 2012-08-09 | 2014-02-13 | Bristol-Myers Squibb Company | Tricyclic alkene derivatives as hiv attachment inhibitors |
WO2014160692A1 (en) * | 2013-03-27 | 2014-10-02 | Bristol-Myers Squibb Company | 2-keto amide derivatives as hiv attachment inhibitors |
US20160052923A1 (en) * | 2013-03-27 | 2016-02-25 | Bristol-Myers Squibb Company | Piperazine and homopiperazine derivatives as hiv attachment inhibitors |
GB201321748D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
JP2018500323A (ja) * | 2014-12-18 | 2018-01-11 | ヴィーブ ヘルスケア ユーケー(ナンバー4)リミテッド | PyBroPを使用してハロゲン化アザインドール化合物を調製するための方法 |
JP6554542B2 (ja) * | 2014-12-18 | 2019-07-31 | ヴィーブ ヘルスケア ユーケー(ナンバー4)リミテッド | ボロキシンを使用してハロゲン化アザインドール化合物を調製するための方法 |
US9518057B2 (en) * | 2014-12-30 | 2016-12-13 | Novira Therapeutics, Inc. | Derivatives and methods of treating hepatitis B infections |
US10153966B1 (en) * | 2015-03-12 | 2018-12-11 | Alarm.Com Incorporated | Hybrid mesh network monitoring signaling environment |
EP3464286B1 (en) | 2016-05-24 | 2021-08-18 | Genentech, Inc. | Pyrazolopyridine derivatives for the treatment of cancer |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4354924A (en) * | 1980-06-25 | 1982-10-19 | Chevron Research Company | Dual component chromia silicate cracking catalyst |
US4812462A (en) * | 1986-04-01 | 1989-03-14 | Warner-Lambert Company | 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity |
US6469006B1 (en) | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
US6476034B2 (en) | 2000-02-22 | 2002-11-05 | Bristol-Myers Squibb Company | Antiviral azaindole derivatives |
US6573262B2 (en) | 2000-07-10 | 2003-06-03 | Bristol-Myers Sqibb Company | Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
PT1363705E (pt) | 2001-02-02 | 2012-08-17 | Bristol Myers Squibb Co | Composição e actividade antiviral de derivados de piperazina azaindoleoxoacética substituídos |
US6825201B2 (en) | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
US20030236277A1 (en) | 2002-02-14 | 2003-12-25 | Kadow John F. | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
US20040063744A1 (en) | 2002-05-28 | 2004-04-01 | Tao Wang | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
US7348337B2 (en) * | 2002-05-28 | 2008-03-25 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
AU2003273608A1 (en) | 2002-06-11 | 2003-12-22 | Bristol-Myers Squibb Company | Viral envelope mediated fusion assay |
US6900206B2 (en) | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
US20040063746A1 (en) | 2002-07-25 | 2004-04-01 | Alicia Regueiro-Ren | Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
AU2003290647A1 (en) | 2002-11-08 | 2004-06-03 | Bristol-Myers Squibb Company | Pharmaceutical compositions and methods of using taxane derivatives |
US20050075364A1 (en) * | 2003-07-01 | 2005-04-07 | Kap-Sun Yeung | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
MXPA06001762A (es) | 2003-08-14 | 2006-05-12 | Pfizer | Derivados de piperazina. |
US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
US7776863B2 (en) | 2004-03-24 | 2010-08-17 | Bristol-Myers Squibb Company | Methods of treating HIV infection |
US20050215544A1 (en) | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
US20050215543A1 (en) | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
DE102004020908A1 (de) * | 2004-04-28 | 2005-11-17 | Grünenthal GmbH | Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen |
US7449476B2 (en) | 2004-05-26 | 2008-11-11 | Bristol-Myers Squibb Company | Tetrahydrocarboline antiviral agents |
WO2005121094A1 (en) | 2004-06-09 | 2005-12-22 | Pfizer Limited | Piperazine and piperidine derivatives as anti-hiv-agents |
US7396830B2 (en) | 2005-10-04 | 2008-07-08 | Bristol-Myers Squibb Company | Piperazine amidines as antiviral agents |
US7851476B2 (en) | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
WO2007103456A2 (en) | 2006-03-06 | 2007-09-13 | Trimeris, Inc. | Piperazine and piperidine biaryl derivatives |
US7807671B2 (en) * | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
US7504399B2 (en) | 2006-06-08 | 2009-03-17 | Bristol-Meyers Squibb Company | Piperazine enamines as antiviral agents |
-
2009
- 2009-06-24 CN CN200980133292.3A patent/CN102131810B/zh not_active Expired - Fee Related
- 2009-06-24 WO PCT/US2009/048427 patent/WO2009158394A1/en active Application Filing
- 2009-06-24 EP EP09770927.3A patent/EP2303876B1/en not_active Not-in-force
- 2009-06-24 US US12/490,714 patent/US7960406B2/en active Active
- 2009-06-24 ES ES09770927.3T patent/ES2462403T3/es active Active
- 2009-06-24 JP JP2011516575A patent/JP5433690B2/ja not_active Expired - Fee Related
-
2011
- 2011-05-05 US US13/101,591 patent/US8124615B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20100009993A1 (en) | 2010-01-14 |
US8124615B2 (en) | 2012-02-28 |
EP2303876B1 (en) | 2014-03-19 |
CN102131810A (zh) | 2011-07-20 |
JP2011526283A (ja) | 2011-10-06 |
US7960406B2 (en) | 2011-06-14 |
US20110212971A1 (en) | 2011-09-01 |
WO2009158394A1 (en) | 2009-12-30 |
EP2303876A1 (en) | 2011-04-06 |
ES2462403T3 (es) | 2014-05-22 |
CN102131810B (zh) | 2014-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5433690B2 (ja) | 抗−hiv薬としてのジケト縮合アゾロピペリジンおよびアゾロピペラジン | |
US8039486B2 (en) | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives | |
US8664213B2 (en) | Spiro bicyclic diamine derivatives as HIV attachment inhibitors | |
WO2007041616A1 (en) | Piperazine amidines as antiviral agents | |
EP2895475B1 (en) | Tricyclic amidine derivatives as hiv attachment inhibitors | |
EP2895471B1 (en) | Piperidine amide derivatives as hiv attachment inhibitors | |
ES2616432T3 (es) | Derivados de alquenos tricíclicos como inhibidores de la unión del VIH | |
WO2002062423A1 (en) | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives | |
JP5433691B2 (ja) | Hiv結合阻害剤としてのジケトピペリジン誘導体 | |
WO2012019003A1 (en) | Substituted indole and azaindole oxoacetyl piperazinamide derivatives | |
EP1751161B1 (en) | Diazaindole-dicarbonyl-piperazinyl antiviral agents | |
US20040063746A1 (en) | Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives | |
JP2016515579A (ja) | Hiv結合阻害剤としてのピペラジンおよびホモピペラジン誘導体 | |
US8685982B2 (en) | Thioamide, amidoxime and amidrazone derivatives as HIV attachment inhibitors | |
JP6533514B2 (ja) | Hiv結合阻害剤としての2−ケトアミド誘導体 | |
ES2347192T3 (es) | Derivados de alqueno piperidina como agentes antivirales. | |
ES2386740T3 (es) | PIPERAZIN-ENAMINAS como agentes antivirales | |
ES2368430T3 (es) | Indol, azaindol y derivados de piperazina n-sustituida heterocíclica relacionados. | |
WO2011159794A1 (en) | Deuterated hiv attachment inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120605 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120605 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131112 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131114 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131209 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5433690 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |